Existing joint erosions increase the risk of joint space narrowing independently of clinical synovitis in patients with early rheumatoid arthritis

por Landewé, Robert, Smolen, Josef S, Florentinus, Stefan, Chen, Su, Guérette, Benoît, van der Heijde, Désirée
Publicado 2015

Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis

por Keystone, Edward C, Breedveld, Ferdinand C, Kupper, Hartmut, Li, Yihan, Florentinus, Stefan, Sainsbury, Iain
Publicado 2018

Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid...

por Smolen, Josef S, van Vollenhoven, Ronald F, Florentinus, Stefan, Chen, Su, Suboticki, Jessica L, Kavanaugh, Arthur
Publicado 2018

Linking community pharmacy dispensing data to prescribing data of general practitioners

por Florentinus, Stefan R, Souverein, Patrick C, Griens, Fabiënne AMG, Groenewegen, Peter P, Leufkens, Hubert GM, Heerdink, Eibert R
Publicado 2006

Is new drug prescribing in primary care specialist induced?

por Florentinus, Stefan R, Heerdink, Eibert R, van Dijk, Liset, Griens, AMG Fabiënne, Groenewegen, Peter P, Leufkens, Hubert GM
Publicado 2009

Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis

por Aletaha, Daniel, Maa, Jen-fue, Chen, Su, Park, Sung-Hwan, Nicholls, Dave, Florentinus, Stefan, Furtner, Daniel, Smolen, Josef S
Publicado 2019

Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial

por Burmester, Gerd-Rűdiger, Kivitz, Alan J, Kupper, Hartmut, Arulmani, Udayasankar, Florentinus, Stefan, Goss, Sandra L, Rathmann, Suchitrita S, Fleischmann, Roy M
Publicado 2015

Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid art...

por Kavanaugh, Arthur, van Vollenhoven, Ronald F, Fleischmann, Roy, Emery, Paul, Sainsbury, Iain, Florentinus, Stefan, Chen, Su, Guérette, Benoît, Kupper, Hartmut, Smolen, Josef S
Publicado 2018

Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone

por Keystone, Edward C, Breedveld, Ferdinand C, van der Heijde, Désirée, van Vollenhoven, Ronald F, Emery, Paul, Smolen, Josef S, Sainsbury, Iain, Florentinus, Stefan, Kupper, Hartmut, Chen, Kun, Kavanaugh, Arthur
Publicado 2017